SoftBank has quietly built a $5 billion stake in Roche, becoming one of the Swiss pharmaceutical giant’s largest shareholders, Bloomberg reported. SoftBank is betting on Roche in part because of the company’s biotechnology subsidiary Genentech, which uses data to discover and develop new drugs, according to Bloomberg. Healthcare technology is one of the areas that SoftBank has been focusing...
SoftBank Builds $5 Billion Stake in Drug Giant Roche
Get access to exclusive coverage
Read deeply reported stories from the largest newsroom in tech.
Stay in the know
Receive a summary of the day's top tech news—distilled into one email.
Access on the go
View stories on our mobile app and tune into our weekly podcast.


Join live video Q&A’s
Deep-dive into topics like startups and autonomous vehicles with our top reporters and other executives.
Enjoy a clutter-free experience
Read without any banner ads.

Recent Popular Stories
Exclusive
google
semiconductors
To Reduce AI Costs, Google Wants to Ditch Broadcom as Its TPU Server Chip Supplier